Companies
(73)
AAC Clyde Space
ALM Equity
Alzinova
Arion Bank
Arlandastad Group
Ascelia Pharma
Bactiguard
Bergman & Beving
Besqab
BioPorto
Björn Borg
Bokusgruppen
Bonava
BTS Group
Byggmästaren
CAG Group
Calviks
Carasent
CDON
Clavister
Clemondo Group
eEducation Albert
Elanders
Elicera Therapeutics
Eolus
Ependion
EQL Pharma
Faron Pharmaceuticals
FluoGuide
Gentoo Media
GiG Software
HAKI Safety
HANZA
Iconovo
Idun Industrier
InfraCom
Initiator Pharma
Intervacc
ITAB Group
Kebni
Lifecare ASA
Lindex Group
Logistri
Lumi Education Group
Lytix Biopharma
Medivir
Mentice
Micro Systemation
MilDef Group
Net Insight
Nordic LEVEL Group
Orexo
Ortoma
OssDsign
Paxman
Pierce
PowerCell
Pricer
Qualisys
Relais Group
SaltX
Scanfil
Sensys Gatso Group
Sleep Cycle
Solar Foods
Spago Nanomedical
Svedbergs Group
Taaleri
Terranor
Vertiseit
Vivesto
W5 Solutions
Waystream
Sweden
Capital Goods
Latest share price
SEK
20 Nov 2026 17:29 CET
Fair value range
SEK
23 Oct 2025
Market cap
SEK
m
Next report
5 Feb 2027
Bergman & Beving
Capital Goods
2026-10-21
After a slow summer, demand for Bergman & Beving’s (B&B) products improved in September and the company expects demand to gradually improve in the coming quarters. We...
Post-Results Note
Markus Almerud
Green shoots - Q2 review
Continued EBITA growth - Q2 initial
Expecting deal activity to pick up in fiscal H2 - Q2 preview
Bergman & Beving
Capital Goods
2026-10-21
Demand for Bergman & Beving’s (B&B) products was mixed but with the impact from the Skydda divestment behind it, the net impact from M&A was once again positive. The...
News
Markus Almerud
Green shoots - Q2 review
Continued EBITA growth - Q2 initial
Expecting deal activity to pick up in fiscal H2 - Q2 preview
Bergman & Beving
Capital Goods
2026-10-19
We maintain our fair value range of SEK300–380. We expect the market to have remained muted in the past quarter, but we will focus on green shoots in the construction...
Pre-Results Note
Markus Almerud
Green shoots - Q2 review
Continued EBITA growth - Q2 initial
Expecting deal activity to pick up in fiscal H2 - Q2 preview
Price
Fair range high value
Fair range low value
Year
2024
2025
2026e
2027e
2028e
EPS
-1.93
8.50
9.18
11.05
12.30
EPS (Adj.)
8.07
8.65
9.18
11.05
12.30
Sales Growth
5.27%
5.71%
4.32%
3.00%
EPS Growth (Adj.)
13.29%
7.15%
6.15%
20.37%
11.27%
P/E
30.2
28.0
23.2
20.9
P/E (Adj.)
31.8
29.7
28.0
23.2
20.9
EV/EBITA
42.5
17.5
15.8
13.7
12.5
EV/EBITDA
12.8
12.2
11.7
10.2
9.3
Learn more
Sector
Capital Goods
Country
Sweden
Tickers
BERGB@SS, BERGb.ST
CEO
Magnus Söderlind
CFO
Peter Schön
Webpage
www.bergmanbeving.com
About DNB Carnegie Access
DNB Carnegie Access aim is to connect listed companies with the capital markets. Through top ranked public equity research and broad distribution via written reports, seminars, video, and podcasts, we increase visibility and investor understanding for small- and medium-sized companies, both among institutional and private investors.
Along with corporate finance, market making and certified advisory we provide a complete product offering to our clients.
Private Banking
Tailored wealth management. Your financial future, personalized.
Montrose
A digital investment platform designed for passionate investors.
DNB Carnegie
Leading Nordic investment bank and wealth management.
© Copyright DNB Carnegie Investment Bank AB